olomoucine has been researched along with 4,5-diphenyl-2,3-dihydro-1H-pyrazolo[3,4-c]pyridazin-3-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acero, N; Braña, MF; Cacho, M; de Pascual-Teresa, B; García, ML; Llinares, F; López, B; Lozach, O; Mayoral, EP; Meijer, L; Muñoz-Mingarro, D; Ramos, A | 1 |
1 other study(ies) available for olomoucine and 4,5-diphenyl-2,3-dihydro-1H-pyrazolo[3,4-c]pyridazin-3-one
Article | Year |
---|---|
Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; CDC2 Protein Kinase; Cell Line, Tumor; Cyclin B; Cyclin-Dependent Kinase 2; Drug Screening Assays, Antitumor; Humans; Ligands; Models, Molecular; Pyrazoles; Pyridazines; Structure-Activity Relationship; Thermodynamics | 2005 |